Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.97016
Revised: August 26, 2024
Accepted: December 2, 2024
Published online: March 16, 2025
Processing time: 297 Days and 17.2 Hours
Intestinal ultrasound (IUS) is a safe and effective way for the diagnosis and surveillance of patients with inflammatory bowel disease (IBD). It allows a noninvasive and reproducible follow-up for patients with IBD.
To compare the outcomes of colonoscopy and IUS in diagnosing and monitoring patients with IBD.
A prospective study was conducted over a three-year period (January 2021 to April 2024) comparing endoscopic and IUS findings. A total of 101 patients were included in the study (68 with Crohn’s disease and 33 with ulcerative colitis). All patients underwent both IUS and colonoscopy within a 10-day period.
The study found a strong correlation between bowel thickening on IUS and inflammatory activity (P = 0.004), IUS remission and endoscopic remission (P = 0.03), IUS and endoscopic location (P = 0.04), as well as IUS and computed tomography scan findings for collection diagnosis (P < 0.01).
The study’s findings demonstrated excellent results for using IUS in the diagnosis and follow-up of IBD patients.
Core Tip: This is the first single-blind prospective study conducted to compare the results of ultrasound and colonoscopy. Our goal is to present an objective comparison between intestinal ultrasound (IUS) and colonoscopy. All the patients with inflammatory bowel disease (Crohn’s or ulcerative colitis) were contacted by the same investigator (Dr. Hajar Cherkaoui) in a delay of 10 days of colonoscopies. The operator (Dr. Hakima Abid) did not know the results of colonoscopies while performing the IUS. This ensured objective, unbiased evaluation of IUS in the diagnosis and follow-up of inflammatory bowel disease patients.
